Seasonal variation in ambulatory blood pressure control in patients on clinic blood pressure-guided antihypertensive treatment

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved..

BACKGROUND: We investigated seasonal variation in ambulatory blood pressure control in hypertensive patients on clinic blood pressure-guided antihypertensive treatment.

METHODS: The study participants were hypertensive patients enrolled in an 8-week therapeutic study. Antihypertensive treatment was initiated with long-acting dihydropyridine calcium channel blockers amlodipine 5 mg/day or the gastrointestinal therapeutic system (GITS) formulation of nifedipine 30 mg/day, with the possible up-titration to amlodipine 10 mg/day or nifedipine-GITS 60 mg/day at 4 weeks of follow-up.

RESULTS: The proportion of up-titration to higher dosages of antihypertensive drugs at 4 weeks of follow-up was higher in patients who commenced treatment in autumn/winter ( n  = 302) than those who commenced treatment in spring/summer ( n  = 199, 24.5 vs. 12.0%, P  < 0.001). The control rate of clinic blood pressure, however, was lower in autumn/winter than in spring/summer at 4 (56.7 vs. 70.7%, P  = 0.003) and 8 weeks of follow-up (52.5 vs. 74.9%, P  < 0.001). At 8 weeks, patients who commenced treatment in autumn/winter, compared with those who commenced treatment in spring/summer, had a significantly ( P ≤0.03) smaller daytime (mean between-season difference -3.2/-2.8 mmHg) but greater nighttime SBP/DBP reduction (3.6/1.6 mmHg). Accordingly, at 8 weeks, the prevalence of nondippers was significantly ( P  < 0.001) higher in spring/summer than in autumn/winter for both SBP (54.8 vs. 30.0%) and DBP (53.4 vs. 28.8%).

CONCLUSION: Clinic blood pressure-guided antihypertensive treatment requires a higher dosage of medication in cold than warm seasons, which may have led to over- and under-treatment of nighttime blood pressure, respectively.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:42

Enthalten in:

Journal of hypertension - 42(2024), 5 vom: 01. Apr., Seite 909-916

Sprache:

Englisch

Beteiligte Personen:

Ye, Xiao-Fei [VerfasserIn]
Wang, Wen-Yuan-Yue [VerfasserIn]
Wang, Xin-Yu [VerfasserIn]
Huang, Qi-Fang [VerfasserIn]
Sheng, Chang-Sheng [VerfasserIn]
Li, Yan [VerfasserIn]
Wang, Ji-Guang [VerfasserIn]

Links:

Volltext

Themen:

1J444QC288
Amlodipine
Antihypertensive Agents
I9ZF7L6G2L
Journal Article
Nifedipine

Anmerkungen:

Date Completed 05.04.2024

Date Revised 05.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1097/HJH.0000000000003666

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM367211777